Zika Vaccines Market Current Industry Trend, Latest Development, Growth Estimation, Analysis by Size, Share, Global Demand Till 2026

Zika vaccines helps in immunization and prevention against the diseases caused by Zika virus. Aedes mosquitoes are the source of this virus that belongs to genus Flavivirus. Blood transfusion and sexual contact can act as transmitting medium for the virus. Moreover, the virus can also transmitted from an infected pregnant women to her fetus. PCR is used to detect the viral DNA during the diagnosis of the infection. However, only 1 in every 4 people with zika infection are prone to develop symptoms. In November 2016, the World Health Organization (WHO) declared that zika infection no longer constitutes a Public Health Emergency of International Concern (PHEIC) as major cases of zika virus were asymptomatic.

Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/413

In April 2015, Brazil witnessed a major outbreak of Zika virus, which later spread in South and Central America. Major symptoms during the outbreak included mild illness (fever, rashes, joint pains, conjunctivitis, nausea, and muscle pain). The recent outbreaks also demonstrated severe complications such as microcephaly, Guillain-Barré syndrome, and various congenital neurological abnormalities in infants who were born to infected mothers. The link between zika virus and microcephaly and Guillain-Barré syndrome was identified and reported in 2015 in Brazil.

According to the Centers for Disease Control and Prevention (CDC), in 2015, 70 new zika virus infection cases were reported in the U.S., which increased to 41,181 cases in 2016. Low prevalence of the infection in 2015 can be attributed to lack of reporting. Growing awareness about the infection among the populace can lead to high number of diagnosis and reporting of the infection, thereby contributing to growth of the global zika vaccines market.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/413

Major institutes and universities are focused on R&D related to the Zika virus infection, which is also contributing to growth of the market. For instance, researchers at the Queensland University of Technology found that the extract of San Francisco plant (Codiaeum variegatum) found in Australia, can eliminate the zika virus. This extract can arrest the virus and stop it from replicating without causing any damage to the host cells.

Zika Vaccines Market Taxonomy:

There are different types of vaccines that provide protection against Zika virus:

• DNA-based vaccines
• Inactivated vaccines
• Live-attenuated vaccines
• mRNA vaccines
• Genetically engineered vaccines

Global market by application:

• Therapeutic Vaccines
• Preventive Vaccines

Global market by end user:

• Hospitals
• Clinics

Increasing number of human clinical trials and high prevalence of zika virus infection is expected to boost growth of the Zika vaccines market

Major institutes and universities are focused on R&D related to the Zika virus infection, which is contributing to growth of the market. For instance, as of March 2016, 67 companies and research institutions were working on various kinds of R&D projects and clinical trials that aided in development of effective vaccines against zika virus. In June 2016, the U.S. FDA approved the first human clinical trial for GLS–5700, a zika vaccine by Inovio Pharmaceuticals. Similarly, in 2017, a grant was approved for phase 2 clinical trials for a DNA vaccine conducted by NIAID’s Vaccine Research Center (VRC).

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/zika-vaccines-market-413

Major government and private organizations are focused on increasing awareness about the infection among the populace, which also contributes to the market growth. For instance, in February 2016, the World Health Organization (WHO) implemented a global framework for creating public awareness through its Zika Strategic Response Framework and Joint Plan. This plan outlines all the points to be taken care of at the time of infections. Moreover, in June 2016, WHO Regional Office for Europe developed a training curriculum to increase awareness by the publication of Zika Risk Assessment for European Region.

However, development and commercialization of zika virus vaccines is costly, which is expected to hamper growth of the global zika vaccines market.

The Zika virus infection is more prevalent in tropical regions such as Brazil, Paraguay, Venezuela, Colombia, and Suriname. The infection can also spread in tropical areas of the U.S. such as Texas and Florida. For instance, according to Pan American Health Organization, around 1,246 suspected and confirmed cases were reported between epidemiological week (EW) 10 and EW 14 of 2016 in the sub region, which involves Brazil, Argentina, Peru and Ecuador.

Competitive Landscape

Key players in the market are focused on conducting clinical trials and launching new products to expand their product portfolio. For instance, in February 2016, Sanofi S.A launched a vaccine research and development project, with the introduction of Dengvaxia (Dengue vaccine) that will aid the company understand the Zika virus and develop an effective vaccine against it. Similarly, in August 2016, Inovio Pharmaceuticals initiated a clinical study of zika vaccine (GLS-5700) in Puerto Rico.

Major players operating in the global zika vaccines market include, Inovio Pharmaceuticals, Immunovaccine Inc., Cerus Corporation, Biken Inc., Bharat Biotech International Pvt. Ltd, GlaxoSmithKline plc., GeneOne Life Science, NewLink Genetics Corp., and Sanofi S.A.

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837